This contract expires in 324 days (Sep 14, 2027).
LOYOLA UNIVERSITY OF CHICAGO - MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS
Key Details
Description
MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS
Context & Analysis
On Sep 8, 2026, Department of Health and Human Services obligated $350,000 to LOYOLA UNIVERSITY OF CHICAGO for modification to the a11 herv-e tcr and t cell product toimprove the therapeutic efficacy for ccrcc patients. The award is classified under NAICS 622110 — GENERAL MEDICAL AND SURGICAL HOSPITALS. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in MAYWOOD, IL. The contract is scheduled through Sep 14, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 622110 — related awards are listed below.
Contractor Information
Similar Awards
EMERGENCY MEDICINE PHYSICIAN AND NURSING SERVICES, AT THE FORT YATES HOSPITAL (FYH), FORT YATES, ND
BAY AREA ANESTHESIA LLC
$5.9M
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
VANDERBILT UNIVERSITY MEDICAL CENTER
$5.3M
OMAHA BENEFICIARIES ED AND INPATIENT SERVICES
WINNEBAGO TRIBE OF NEBRASKA
$3.4M
COMPREHENSIVE HEALTH SERVICES FOR THE ELIGIBLE URBAN INDIAN POPULATION OF SANTA BARBARA, CALIFORNIA. THE AWARD WILL BE DONE PRIOR TO APRIL 1, 2025 FOR A NEW UIO FAR FIRM FIXED PRICED CONTRACT FOR SANTA BARBARA CA.
AMERICAN INDIAN HEALTH & SERVICES CORPORATION
$3.3M
SUBURBAN HOSPITAL:
SUBURBAN HOSPITAL, INC
$3.1M
Stay Updated
Get notified about new opportunities matching your interests.